VANGUARD GROUP INC 13D and 13G filings for Evolent Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Evolent Health, Inc. EVH | VANGUARD GROUP INC | 10,821,331 9.410% | 1,030,515 (+10.53%) | Filing |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Evolent Health, Inc. EVH | VANGUARD GROUP INC | 9,790,816 9.680% | 2,244,824 (+29.75%) | Filing |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Evolent Health, Inc. EVH | VANGUARD GROUP INC | 7,545,992 8.440% | 443,328 (+6.24%) | Filing |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | Evolent Health, Inc. EVH | VANGUARD GROUP INC | 7,102,664 8.280% | 216,247 (+3.14%) | Filing |